Health
Virus drug benefit only marginal: study – Tenterfield Star
Moderately ill COVID-19 patients had their condition improve after a 5-day course of Gilead Sciences Inc’s remdesivir but the drug did not significantly short…
Moderately ill COVID-19 patients had their condition improve after a 5-day course of Gilead Sciences Inc’s remdesivir but the drug did not significantly shorten hospital stays and a 10-day course did not show a benefit, according to new data.
The drug, which was shown in a trial of severely ill COVID-19 patients to shorten their hospital recovery time, has been at the forefront of the battle against the pandemic.
The 600-patient analysis, published on Friday by the Journal of the American Medi…
-
Noosa News12 hours agoBondi Beach terror attack: Police investigate threat against Westfield North Lakes in Queensland
-
General23 hours agoICAC investigating University of Wollongong as chancellor grilled at Inquiry
-
Noosa News22 hours agoE-Scooter accident | Noosa Today
-
General24 hours agoDon’t rush to change gun laws after Bondi, farmers and shooters group in Tasmania says